FDA approves CDTX’s Rezzayo—(rezafungin)—for treatment of candidemia/candidiasis: https://www.globenewswire.com/news-release/2023/03/22/2632765/0/en/Cidara-Therapeutics-and-Melinta-Therapeutics-Announce-FDA-Approval-of-REZZAYO-rezafungin-for-injection-for-the-Treatment-of-Candidemia-and-Invasive-Candidiasis.html